Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Chang Gung Memorial Hospital)
- Development stage
- Unknown
- Lead developer
- Chang Gung Memorial Hospital
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Cell Therapies, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Endoscopic
01
Overview
Fecal microbiota transplantation (FMT) is an investigational live biotherapeutic product being developed by Chang Gung Memorial Hospital for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease (GI-GvHD). Acute GI-GvHD is a severe complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and is associated with high mortality and reduced gut microbiota diversity. FMT aims to restore a healthy and diverse gut microbiome by introducing microbiota from a healthy donor. This is believed to regulate the recipient's immune responses and improve intestinal homeostasis. Chang Gung Memorial Hospital is conducting a Phase II, single-arm trial (NCT07364617) to evaluate the safety and efficacy of FMT in this patient population. [1]
- Other names
- FMTfecal microbiota transplantation
Beyond the preview
Go deeper on fecal microbiota transplant (Chang Gung Memorial Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Chang Gung Memorial Hospital).